Plains GP (PAGP) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $1.97
- EPS estimate
- $0.46
- EPS surprise
- +331.54%
- Revenue surprise
- +37.53%
- Revenue
- $17.7B
- Revenue estimate
- $12.9B
- Reported
- Aug 7, 2026
Plains GP reported Q2 2026 results on August 7, 2026. Earnings per share were $1.97, far above the $0.46 estimate, a beat of 331.54%. Revenue was $17.7 billion, 37.53% above the $12.9 billion consensus. Both figures were the highest in the table. In Q2 2025, Plains GP earned $0.15 per share on revenue of $10.6 billion, so revenue rose about 67% year over year.
Before Q2 2026, Plains GP had beaten the EPS estimate only once in the table, in Q4 2021, and missed 18 of the last 20 quarters overall. Q1 2026 came in at $0.10 against a $0.46 estimate. Annual EPS was $0.86 in 2022, $1.02 in 2023, $0.53 in 2024 and $1.29 in 2025. Q2 2026 alone exceeded each of those full-year totals. The table shows two losing quarters, Q3 2021 at $0.12 per share and Q4 2024 at $0.05. Revenue otherwise moved between $10.6 billion and $16.4 billion per quarter.
Q3 results came out between November 2 and November 8 in each of the past five years. That points to early November 2026 for the next report. A year earlier, Q3 EPS was $0.41.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 7, 2026 | $0.46 | $1.97 | +331.54% | $17.7B | SEC |
| Q1 2026 | May 8, 2026 | $0.46 | $0.10 | −78.09% | $12.5B | SEC |
| Q4 2025 | Feb 6, 2026 | $0.49 | $0.31 | −37.12% | $10.6B | SEC |
| Q3 2025 | Nov 5, 2025 | $0.42 | $0.41 | −2.15% | $11.6B | SEC |
| Q2 2025 | Aug 8, 2025 | $0.39 | $0.15 | −61.72% | $10.6B | SEC |
| Q1 2025 | May 9, 2025 | $0.43 | $0.42 | −2.76% | $12.0B | SEC |
| Q4 2024 | Feb 7, 2025 | $0.46 | −$0.05 | −110.97% | $12.4B | SEC |
| Q3 2024 | Nov 8, 2024 | $0.38 | $0.17 | −55.68% | $12.7B | SEC |
| Q2 2024 | Aug 2, 2024 | $0.39 | $0.20 | −49.29% | $12.9B | SEC |
| Q1 2024 | May 3, 2024 | $0.47 | $0.21 | −55.37% | $12.0B | SEC |
| Q4 2023 | Feb 9, 2024 | $0.40 | $0.27 | −32.09% | $12.7B | SEC |
| Q3 2023 | Nov 3, 2023 | $0.30 | $0.15 | −50.12% | $12.1B | SEC |
| Q2 2023 | Aug 4, 2023 | $0.26 | $0.25 | −3.25% | $11.6B | SEC |
| Q1 2023 | May 5, 2023 | $0.43 | $0.35 | −19.02% | $12.3B | SEC |
| Q4 2022 | Feb 8, 2023 | $0.40 | $0.23 | −42.98% | $13.0B | SEC |
| Q3 2022 | Nov 2, 2022 | $0.47 | $0.36 | −24.07% | $14.3B | SEC |
| Q2 2022 | Aug 3, 2022 | $0.41 | $0.16 | −61.21% | $16.4B | SEC |
| Q1 2022 | May 4, 2022 | $0.49 | $0.11 | −77.45% | $13.7B | SEC |
| Q4 2021 | Feb 9, 2022 | $0.22 | $0.43 | +95.45% | $13.0B | SEC |
| Q3 2021 | Nov 2, 2021 | $0.17 | −$0.12 | −170.71% | $10.8B | SEC |
Quarterly revenue
Frequently asked questions
When did Plains GP (PAGP) last report earnings?
Plains GP last reported on Aug 7, 2026, covering fiscal Q2 2026.
Did PAGP beat earnings estimates?
Yes. Plains GP reported EPS of $1.97 for Q2 2026 against a $0.46 estimate — a 331.54% beat.
How much revenue did PAGP report last quarter?
Plains GP reported $17.7B in revenue for Q2 2026, against a consensus estimate of $12.9B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.